ClinicalTrialsFinder
RecruitingNCT06308055

Abiomed Impella RT-DAQ - Observational Study

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Sponsor

Abiomed Inc.

Enrollment

125 participants

Start Date

Oct 4, 2024

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock

Summary

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Ongoing or planned intensive care management with Impella support
  • Presence or planned placement of a cardiac output measurement
  • Preferentially pulmonary catheter (including cardiac output (CO) preferred as continuous measurement)
  • Other means of discontinuous CO measurement incl. echocardiography, other thermodilution methods

Exclusion Criteria3

  • Age < 18 years
  • Pregnancy
  • Anticipated support duration <24 h

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData Acquisition

Develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module.

Locations(4)

Uniklinik RWTH Aachen

Aachen, North Rhine-Westphalia, Germany

UKSH Campus Kiel

Kiel, Schleswig-Holstein, Germany

IRCCS Ospedale San Raffaele

Milan, MI, Italy

Universitätsspital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06308055

Related Trials

Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)

NCT075972911 location

BEAT-SHOCK Registry

NCT076436101 location

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science

NCT076191441 location

Altshock-2 REGISTRY

NCT042952521 location

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

NCT056990051 location